CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis

Clinical and Experimental Immunology

Volumn 117, Issue 1, 1999, Pages 138-146

  Iglesias, J ^a   Matamoros, N ^a   Raga, S ^a   Ferrer, J M ^a   Mila, J ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Apoptosis; CD95 antigen; CVID; T cell subpopulations

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; FAS ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IMMUNOREGULATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

AGAMMAGLOBULINEMIA; ANTIGENS, CD95; APOPTOSIS; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GENETIC HETEROGENEITY; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOPENIA; MALE; T-LYMPHOCYTE SUBSETS; X CHROMOSOME;

EID: 0032972377     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00946.x     Document Type: Article

References (38)

1. Spickett GP, Webster ADB, Farrant J. Cellular abnormalities in common variable immunodeficiency, Immunodef Rev 1990; 2:199-219.
2. Spickett GP, Matamoros N, Farrant J. Lymphocyte surface phenotype in common variable immunodeficiency. Dis Markers 1992; 10:67-80.
3. Farrant J, Spickett GP, Matamoros N et al. Study of B and T cell phenotypes in blood from patients with common variable immuno-deficiency (CVID). Immunodeficiency 1994; 5:159-69.
4. Iglesias J, Raga S, Ferrer JM et al. Expresión y función de CD95 en subpoblaciones linfocitarias T y B de pacientes con Immunodeficiencia Variable Commún (IVC). Inmunología 1997; 16:38.
5. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and cell death. Cell 1994; 76:959-62.
6. Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-43.
7. Nagata S, Golstein P. The Fas death factor. Science 1995; 267:1449-56.
8. Schmid Y, Ulttenbogaart CH, Keld B et al. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 1994; 170:145-57.
9. Saxon A, Keld B, Díaz-Sanchez D et al. B cells from a distinct subset of patients with common variable immunodeficiency (CVID) have increased CD95 (Apo-1/fas), diminished CD38 expression, and undergo enhanced apoptosis. Clin Exp Immunol 1905; 102:17-25.
10. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169:1747-56.
11. Trauth BC, Klas C, Peters AM et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245:301-5.
12. Alderson MR, Armitage RJ, Maraskovsky E et al. Fax transduces activation signals in normal human T lymphocytes. J Exp Med 1993; 178:2231-5.
13. Wesselborg S, Janssen O, Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993; 150:4338-45.
14. Mapara MY, Bargou R, Zugck C. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl-2 oncogene expression. Eur J Immunol 1993; 23:702-8.
15. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152:3685-92.
16. Mysler E, Bini P, Drappa J et al. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 1994; 93:1029-34.
17. Amasaki Y, Kobayashi S, Takeda T et al. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): A possible mechanism for lymphopenia. Clin Exp Immunol 1995; 99:245-50.
18. Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis. Immunol Today 1990; 12:102-5.
19. Katsikis PD, Wunderlich ES, Smith CA et al. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995; 181:2029-36.
20. Silvestris F, Cafforio P, Frassanito MA et al. Overexpression of Fas antigen in advanced HIV-1 infection: Differential ligation constantly induces apoptosis. AIDS 1996; 10:131-41.
21. Kruger G, Welte K, Ciobanu N et al. Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common variable immunodeficiency. J Clin Immunol 1984; 4:295-300.
22. Eisenstein EM, Jaffe JS, Strober W. Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation. J Clin Immunol 1993; 13:247-51.
23. 2-microblobulin in common variable immunodeficiency. Clin Exp Immunol 1991; 86:252-8.
24. Aukrust P, Frolan SS, Müller F. Raised serum neopterin levels in patients with primary hypogammaglobulinaemia: Correlation to other immunological parameters and to clinical and histological features. Clin Exp Immunol 1992; 89:211-8.
25. Debatin KM, Fabring-Faissner A, Enenkel-Stoodt S et al. High exprension of Apo-1 (CD95) on T lymphocytes from human immunodeficiency virus-1 infected children. Blood 1994; 83:3101-3.
26. McCloskey TW, Oyaizu N, Kaplan M et al. Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry 1995; 22:111-4.
27. Hockenherry S, Nuñez G, Milliman C. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348:334-6.
28. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995; 13:513-43.
29. Van Der Vliet HJJ, Wever PC, Van Diepen FNJ et al. Quantification of Bax/Bcl-2 ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosis. Clin Exp Immunol 1997; 110:324-8.
30. Cheng J, Zhow T, Liu Ch et al. Protection from Fas-mediated apoptosis by a soluble form of Fas molecule. Science 1994; 263:1759-62.
31. Tokano Y, Miyake S, Kayagaki N et al. Soluble Fas molecule in the serum of patients with systemic lupus erythematosus. J Clin Immunol 1996; 16:261-5.
32. Estaquier J, Idziorek T, Zou W et al. T helper type 1/T helper type 2 cytokines and T cell death: Preventive affect of interleukin 12 on activation-induced and CD95 (Fas/Apo-1) mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 1995; 182:1759-67.
33. North ME, Ivory K, Funauchi M et al. Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin Exp Immunol 1996; 105:517-22.
34. Raga S, Pons J, Iglesias J et al. Niveles elevados de IL-12 e IL-10 en la Inmunodeficiencia Común Variable (ICV). Efecto de la neutralización de la IL-12 in vitro. Inmunología 1998; 17:54.
35. Aukrust P, Müller F, Frolan SS. Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes. Clin Immunol Immunopathol 1994; 70:217-22.
36. Aukrust P, Svardal M, Müller F et al. Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: Possible immunopathogenic role of oxidative stress. Blood 1995; 4:1383-91.
37. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15:7-10.
38. Safarin TA, Bredesen DE. Is apoptosis mediated by reactive oxygen species? Free Rad Res 1994; 21:1-5.